This announcement is a separate document:
科研製薬：有価証券報告書－第103期(2022/04/01－2023/03/31)
Kaken Pharmaceutical: Securities Report - 103rd Period (2022/04/01 - 2023/03/31)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.